In AML patients developing acute respiratory failure shortly after induction chemotherapy with a falling blast count, how often is leukemic cell lysis pneumopathy the cause, and how do you manage these cases?
In AML patients developing acute respiratory failure shortly after induction chemotherapy with a falling blast count, how often is leukemic cell lysis pneumopathy the cause, and how do you manage these cases? | Mednet
